Amiel SA, Simonson DC, Sherwin RS, Lauriano AA, Tamborlane WV (1987). Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children. Journal of Pediatrics 110: 832-7.
Amiel S (1991). Glucose counter-regulation in health and disease: current concepts in hypoglycaemia recognition and response. Quarterly Journal of Medicine 293: 707-27.
Banarer S, Cryer PE (2003). Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes 52: 1195-203.
Bingham EM, Dunn JT, Smith D, Sutcliffe-Goulden J, Reed LJ, Mansden PK, Amiel SA (2005). Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study. Diabetologia 48: 2080-9.
Bolli G, De Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F et al. (1983). Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of antiinsulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32: 134-41.
Bolli GM (2006). Insulin treatment in type 1 diabetes. Endocrine Practice 12 Suppl 1: 105-9.
Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI (1994). Ventromedial hypotha-lamic lesions in rats suppress counter regulatory responses to hypoglycemia. Journal of Clinical Investigation 93: 1677-82.
Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI (1995). Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 44: 180-4.
Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI (1997). Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. Journal of Clinical Investigation 99: 361-5.
Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ (1995). Brain glucose uptake and unawareness of hypoglycemia in patients with insulin dependent diabetes mellitus. New England Journal of Medicine 333: 1726-31.
Brierley EJ, Broughton DL, James OFW, Alberti KGMM (1995). Reduced awareness of hypoglycaemia in the elderly despite an intact counter-regulatory response. Quarterly Journal of Medicine 88:439-45.
Bulsara M, Holman CD, Davies EA, Jones TW (2004). The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care 27: 2293-8.
Chase HP, Horner BP, McFann K, Yetzer H, Gaston J, Banion C et al. (2006). The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control. Diabetes Care 29: 1012-5.
Cheyne E, Kerr D (2002) Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice. Diabetes Metabolism Research Reviews 18 Suppl 1: S43-8.
Choi I Y, Seaquist ER, Gruetter R (2003). Effect of hypoglycemia on brain glycogen metabolism in vivo. Journal of Neuroscience Research 72: 25-32.
Cox DJ, Irving GA, Gonder-Frederick L, Nowacek G, Butterfield J (1987). Fear of hypoglycemia: quantification, validation and utilization. Diabetes Care 10: 617-21.
Cranston I, Lomas J, Maran A, Macdonald IA, Amiel SA (1994). Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344: 283-7.
Cryer PE (2004). Diverse causes of hypoglycemia-associated autonomic failure in diabetes. New England Journal of Medicine 350: 2272-9.
Cryer PE (2005). Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 54: 3592-601.
DAFNE Study Group (2002). Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. British Medical Journal 325: 746.
Davis SN, Shavers C, Costa F, Mosqueda-Garcia R (1996). Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. Journal of Clinical Investigation 98: 680-91.
Davis SN, Shavers C, Davis B, Costa F (1997). Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. Journal of Clinical Investigation 100: 429-38.
Davis SN, Mann S, Galassetti P, Neil R, Tate D, Ertl AC, Costa F (2000a). Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes 49: 1897-903.
Davis SN, Fowler F, Costa S (2000b). Hypoglycemic counterregulatory responses differ between men and women with type 1 diabetes. Diabetes 49: 65-72.
Debrah K, Sherwin RS, Murphy J, Kerr D (1996). Effect of caffeine on recognition of and physiological responses to hypoglycaemia in insulin-dependent diabetes. Lancet 347: 19-24
Diem P, Redmon JB, Abid M, Moran A, Sutherland DE, Halter JB, Robertson RP (1990). Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. Journal of Clinical Investigation 86: 2008-13.
Fisher M, Frier BM (1993). Hypoglycaemia and human insulin. In: Hypoglycaemia and Diabetes: Clinical and Physiological Aspects. Frier BM and Fisher M, eds. Edward Arnold, London: 314-27.
Fisher S, Brunning J, Lannon S, Kahn CR (2005). Insulin signaling in the central nervous system is critical for the normal sympathoadrenal response to hypoglycemia. Diabetes 54: 1447-51.
Flanagan D, Kerr D (1996). Recurrent hypoglycemia and long-standing brittle diabetes. Endocrinology and Metabolism 3: 67-69.
Frier BM, Fisher M, Gray CE, Beastall GH (1988). Counterregulatory hormonal responses to hypo-glycaemia in type 1 (insulin-dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretion. Diabetologia 31: 421-9.
Gabriely I, Shamoon H (2005). Fructose normalizes specific counterregulatory responses to hypoglycemia in patients with type 1 diabetes. Diabetes 54: 609-16.
Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH (1973). Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 182: 171-3.
Gerich JE, Bolli GB (1993). Counterregulatory failure. In: Hypoglycaemia and Diabetes: Clinical and Physiological Aspects. Frier BM and Fisher M, eds. Edward Arnold, London: 253-67.
Guldstrand M, Ahren B, Wredling R, Backman L, Lins P, Adamson U (2003). Alteration of the counterregulatory responses to insulin-induced hypoglycemia and of cognitive function after massive weight reduction in severely obese subjects. Metabolism 52: 900-7.
Hardy KJ, Burge MR, Boyle P, Scarpello JHB (1994). A treatable cause of recurrent severe hypoglycemia. Diabetes Care 17: 722-4.
Heine RJ, Van der Heyden EAP, Van der Veen EA (1989). Responses to human and porcine insulin in healthy subjects. Lancet 334: 946-9.
Heller SR, Cryer PE (1991). Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in non-diabetic humans. Diabetes 40: 223-6.
Hvidberg A, Juel Christensen N, Hilsted J (1998). Counterregulatory hormones in insulin-treated diabetic patients admitted to an Accident and Emergency Department with hypoglycaemia. Diabetic Medicine 15: 199-204.
Jacqueminet S, Masseboeuff N, Rolland M, Grimaldi A, Sachon C (2005). Limitations of the so-called 'intensified' insulin therapy in type 1 diabetes mellitus. Diabetes Metabolism 31(4 Pt 2): 4S45-50.
Jones TW, Boulware SD, Kraemer DT, Caprio S, Sherwin RS, Tamborlane WV (1991). Independent effects of youth and poor diabetes control on responses to hypoglycemia in children. Diabetes 40: 358-63.
Jones TW, Porter P, Sherwin RS, Davis EA, O'Leary P, Frazer F et al. (1998). Decreased epinephrine responses to hypoglycemia during sleep. New England Journal of Medicine 338: 1657-62.
Jorgensen L, Dejgaard A, Pramming SK (1994). Human insulin and hypoglycaemia: a literature survey. Diabetic Medicine 11: 925-34.
Kerr D, Reza M, Smith N, Leatherdale BA (1991). Importance of insulin in subjective, cognitive and hormonal responses to hypoglycemia in patients with IDDM. Diabetes 40: 1057-62.
Kerr D, Tamborlane WV, Rife F, Sherwin RS (1993). Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. Journal of Clinical Investigation 91: 141-7.
Kumagai AK, Kang YS, Boado RJ, Pardridge WM (1995). Upregulation of blood-brain barrier GLUT-1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 44: 1399-404.
McCall AL, Fixman LB, Fleming N, Tornheim K, Chick W, Ruderman NB (1986). Chronic hypoglycemia increases brain glucose transport. American Journal of Endocrinology 251: E442-7.
McCrimmon RJ, Evans ML, Fan X, McNay EC, Chan O, Ding Y et al. (2005). Activation of ATP-sensitive K+ channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. Diabetes 54: 3169-74.
McGuiness O, Ansari T, Potts J, Jacobson L (2005). Glucocorticoid insufficiency in corticotrophin releasing hormone knockout mice does not preserve autonomic responses during repeated hypo-glycemia clamps. Diabetes 54 (Suppl): A26 (abstract).
Merl V, Kern W, Peters A, Oltmanns KM, Gais S, Born J et al. (2004). Differences between nighttime and daytime hypoglycemia counterregulation in healthy humans. Metabolism 53: 894-8.
Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I et al. (1991). Hierarchy of glycemic thresholds for counterregulatory hormonal secretion, symptoms, and cerebral dysfunction. American Journal of Endocrinology 260: E67-74.
Muhlhauser I, Bruckner I, Berger M, Cheta D, Jorgens V, Lonescu-Tirgoviste C et al. (1987). Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Dusseldorf Study. Diabetologia 30: 681-90.
Nehlig A, Daval JL, Debry G (1992). Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Research Reviews 17: 139-69.
Ortiz-Alonso FJ, Galecki A, Herman WH, Smith MJ, Jacquez JA, Halter JB (1994). Hypoglycemia counterregulation in elderly humans: relationship to glucose levels. American Journal of Endocrinology 267: E497-506.
Raju B, McGregor VP, Cryer PE (2003). Cortisol elevations comparable to those that occur during hypoglycemia do not cause hypoglycemia-associated autonomic failure. Diabetes 52: 2083-89.
Richter B, Neises G (2005). 'Human' insulin versus animal insulin in people with diabetes mellitus. Cochrane Database Systematic Reviews Jan 25(1): CD003816.
Ross LA, Warren RE, Kelnar CJ, Frier BM. (2005). Pubertal stage and hypoglycaemia counterregu-lation in type 1 diabetes. Archives of Disease in Childhood 90: 190-4.
Rossing P. (2005) The changing epidemiology of diabetic microangiopathy in type 1 diabetes. Diabetologia 2005; 48: 1439-44.
Samols E, Tyler J, Marks V (1972): Glucagon-insulin interrelationships. In: Glucagon: Molecular Physiology, Clinical and Therapeutic Implications. Lefebvre P, Unger RH, eds. Pergamon, Elmsford NY: 151-174.
Schluter KJ, Petersen KG, Sontheimer K, Enzmann F, Kerp L (1982). Different counterregulatory responses to human insulin (recombinant DNA) and purified pork insulin. Diabetes Care 5 (suppl 2): 78-81.
Segel SA, Fanelli CG, Dence CS, Markham J, Videen TO, Paramore DS et al. (2001). Blood-to-brain glucose transport, cerebral glucose metabolism and cerebral blood flow are not increased following hypoglycemia. Diabetes 50: 1911-17.
Smith D, Pernet D, Reid H, Bingham E, Rosenthal JM, Macdonald IA et al. (2002). The role of hepatic portal glucose sensing in modulating responses to hypoglycaemia in man. Diabetologia 45: 1416-24.
Tappy L, Chiorelo R, Berger M (1999). Autoregulation of glucose production in health and disease. Current Opinions in Clinical Nutrition and Metabolic Care 2: 161-4.
Tattersall RB, Gregory R, Selby C, Kerr D, Heller S (1991). Course of brittle diabetes: 12 year follow up. British Medical Journal 302: 1240-3.
The Diabetes Control and Complications Trial Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329: 977-86.
Thomas M, Sherwin R, Murphy J, Kerr D (1997). Importance of cerebral blood flow on recognition of and physiological responses to hypoglycemia. Diabetes 46: 829-33.
Weintrob N, Schechter A, Benzaquen H, Shalitin S, Lilos P, Galatzer A, Phillip M (2004). Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections versus continuous subcutaneous insulin infusion. Archives of Pediatric and Adolescent Medicine 158: 677-84.
White NH, Gingerich RL, Levandoski LA, Cryer PE, Santiago JV (1985). Plasma pancreatic polypeptide response to insulin-induced hypoglycemia as a marker for defective glucose counterregulation in insulin-dependent diabetes. Diabetes 34: 870-5.
Was this article helpful?